ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

RALPH GUARINO MD

160 STATE HIGHWAY 37 WEST SUITE A DEER CHASE PROFESSIONAL PARK

Toms river | New Jersey | 08755

(732) 286-0440

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,980Medicare Part D Prescriptions Filled, Including Refills

Rank: 321 out of 2094

$796K Total Retail Price of All Prescriptions

Rank: 177 out of 2094

871 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
8% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 7,765 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

40% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$100 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

9 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SIMVASTATIN 311 307 1 1
AZITHROMYCIN 288 279 2 27
LEVOTHYROXINE SODIUM 250 239 3 3
ZOLPIDEM TARTRATE 198 189 4 14
AMLODIPINE BESYLATE 162 162 5 2
ATORVASTATIN CALCIUM 140 135 6 5
METOPROLOL SUCCINATE 133 133 7 9
SYNTHROID 126 126 8 44
CRESTOR 125 122 9 15
SERTRALINE HCL 125 121 9 26
OMEPRAZOLE 119 119 11 4
LISINOPRIL-HYDROCHLOROTHIAZIDE 116 109 12 55
LEVOFLOXACIN 111 109 13 70
EXFORGE 103 93 14 105
LISINOPRIL 102 102 15 7
HYDROCHLOROTHIAZIDE 101 101 16 12
DONEPEZIL HCL 99 99 17 20
DIOVAN HCT 98 93 18 28
METOPROLOL TARTRATE 98 90 18 10
METFORMIN HCL 95 95 20 8
FUROSEMIDE 92 88 21 6
DIOVAN 88 88 22 13
CARVEDILOL 86 82 23 19
TAMSULOSIN HCL 85 83 24 29
BYSTOLIC 79 79 25 83
LIPITOR 78 77 26 39
PREDNISONE 76 76 27 54
ALLOPURINOL 75 69 28 50
AMLODIPINE BESYLATE-BENAZEPRIL 73 71 29 58
TRAMADOL HCL 71 71 30 33
VYTORIN 69 69 31 162
WARFARIN SODIUM 68 68 32 11
NEXIUM 66 66 33 16
PLAVIX 66 65 33 38
ATENOLOL 65 65 35 21
CLOPIDOGREL 65 64 35 22
ALPRAZOLAM 65 58 35 150
TORSEMIDE 64 54 38 118
TRAMADOL HCL-ACETAMINOPHEN 63 63 39 100
MINOCYCLINE HCL 58 56 40 491
LOSARTAN-HYDROCHLOROTHIAZIDE 57 57 41 52
EXFORGE HCT 55 55 42 195
LEVOXYL 55 55 42 130
TRIAMTERENE-HCTZ 54 53 44 87
MECLIZINE HCL 54 54 44 103
CELEBREX 50 50 46 74
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.